Optometric Education Consultants
  • About OEC
  • Case Challenge
  • Conferences
    • Nashville ’25
    • Detroit ’25
    • Scottsdale ’26
    • Pittsburgh ’26
    • Sarasota ’26
    • Amsterdam ’26
    • Disney Resort ’26
    • Quebec ’26
    • Nashville ’26
    • Charleston Recap
    • All Conference Recaps
  • Webinars
  • Recorded Webinars
    Asynchronous
  • YouTube & Resources
Select Page

TQ Quiz | Emerging Trends in AMD (Nashville 2025)

by Events@optometricedu.com | Oct 22, 2025 | 2025 Nashville, TQ Courses | 0 comments

"*" indicates required fields

This field is hidden when viewing the form
MM slash DD slash YYYY
This field is hidden when viewing the form
MM slash DD slash YYYY
This field is hidden when viewing the form
MM slash DD slash YYYY
This field is hidden when viewing the form
1. Current commercially available Spectral Domain OCT is capable of obtaining um resolution.*
2. The earliest ophthalmoscopically detectable feature of AMD is _______.*
3. Which of the following procedures is seldom performed on AMD patients?*
4. The traditional, invasive method for the evaluation of new onset choroidal neovascularization (CNV) in AMD patients is ________.*
5. Ophthalmoscopically, soft drusen appear as _______.*
6. Approximately what percentage of dry (non-exudative) AMD eyes progress to wet (exudative) AMD?*
7. The clinical feature that distinguishes wet AMD from dry AMD is ______.*
8. The "end stage" of dry (non-exudative) AMD is ______.*
9. Your patient has ophthalmoscopic evidence of Macular Neovascularization (MNV). The most important test to perform or order is ______.*
10. Which technique uses low-coherence interferometry to obtain real-time, crosssectional histology of live tissue (virtual biopsy)?*
11. A macular pigment that absorbs harmful blue wavelengths is ______.*
12. Post-treatment AMD patients are monitored frequently because _________.*
13. The AREDS 1 study found that in subjects with intermediate AMD, or advanced AMD in one eye (but not the other):*
14. What is the primary mechanism of action of rho-kinase inhibitors?*
15. Which of the following is the main advantage of Photodynamic therapy (PDT) over traditional laser photocoagulation for CNVM?*
16. Lucentis is used for the treatment of wet (exudative) AMD because of its:*
17. Which of the following is absent in AMD?*
18. According to several epidemiologic studies, the age group with the highest prevalence of AMD is:*
19. Which of the following procedures is least useful in evaluating AMD patients?*
20. There is a significant relationship and similarities between AMD and ________.*

Personal Information

Name*
Address*

Payment Information

After 90 days, pricing will increase to $30.
This field is hidden when viewing the form

Course Information (HIDDEN)

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
Do not include ending backslash (aka no .com/)
This field is hidden when viewing the form

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Upcoming Conferences

Ready to get away this summer or fall. View our upcoming conferences and register today!

View

Case Challenges

Case Challenges

View our library of case challenges and share your comments or questions in the comment box below!

Learn More
For questions and more information, please contact us at events@optometricedu.com

Like and follow us on Facebook, Twitter, and Instagram for conference updates!

Subscribe For Event Updates

* indicates required